ERDERA Clinical Trial Call 2026: Preliminary Announcement and Key Dates

On June 3, 2026, the European Rare Diseases Research Alliance ( ERDERA) published a notice regarding the new Clinical Trial Call 2026 (ECTC), which will be launched on July 1, 2026.

This call for proposals will support transnational Phase I, Phase I/II, and Phase II clinical trials in the field of rare diseases conducted in accordance with the principles of Good Clinical Practice (GCP). 

The aim of the call is to address key challenges in clinical trials for rare diseases, where patient groups are often small and geographically dispersed, and international collaboration is essential. Applicants may include research organizations, universities, hospitals, and other eligible institutions from participating countries (including the Czech Republic). More information is available on the official ERDERA website HERE. For those interested in the call, an informational webinar will be held on July 6 from 3:00 PM to 5:00 PM CEST, during which the terms of the call, applicant eligibility rules, the evaluation process, and other necessary details will be presented. Registration for the webinar is required via this link: ERDERA Clinical Trial Call 2026 – Information Webinar – ERDERA.